116 related articles for article (PubMed ID: 9036839)
1. [Modified nucleoside phosphates as precursors of antineoplastic and antiviral compounds in a cell].
Arzumanov AA; Diatkina NB
Bioorg Khim; 1996; 22(10-11):777-94. PubMed ID: 9036839
[No Abstract] [Full Text] [Related]
2. Phosphorodiamides as prodrugs for antiviral nucleosides.
Shipitsyn AV; Zakirova NF; Belanov EF; Pronyaeva TR; Fedyuk NV; Kukhanova MK; Pokrovsky AG
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):963-6. PubMed ID: 14565322
[TBL] [Abstract][Full Text] [Related]
3. Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules.
Meier C; Balzarini J
Antiviral Res; 2006 Sep; 71(2-3):282-92. PubMed ID: 16735066
[TBL] [Abstract][Full Text] [Related]
4. Intracellular trapping of cycloSal-pronucleotides: modification of prodrugs with amino acid esters.
Jessen HJ; Balzarini J; Meier C
J Med Chem; 2008 Oct; 51(20):6592-8. PubMed ID: 18826203
[TBL] [Abstract][Full Text] [Related]
5. Some new acyclic nucleotide analogues as antiviral prodrugs: synthesis and bioactivities in vitro.
Tang YB; Peng ZG; Liu ZY; Li YP; Jiang JD; Li ZR
Bioorg Med Chem Lett; 2007 Nov; 17(22):6350-3. PubMed ID: 17888662
[TBL] [Abstract][Full Text] [Related]
6. Designing a pronucleotide stratagem: lessons from amino acid phosphoramidates of anticancer and antiviral pyrimidines.
Drontle DP; Wagner CR
Mini Rev Med Chem; 2004 May; 4(4):409-19. PubMed ID: 15134543
[TBL] [Abstract][Full Text] [Related]
7. "Lock-in"-cycloSal-pronucleotides - a new generation of chemical Trojan Horses?
Meier C; Ruppel MF; Vukadinovic D; Balzarini J
Mini Rev Med Chem; 2004 May; 4(4):383-94. PubMed ID: 15134541
[TBL] [Abstract][Full Text] [Related]
8. Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine.
Meppen M; Pacini B; Bazzo R; Koch U; Leone JF; Koeplinger KA; Rowley M; Altamura S; Di Marco A; Fiore F; Giuliano C; Gonzalez-Paz O; Laufer R; Pucci V; Narjes F; Gardelli C
Eur J Med Chem; 2009 Sep; 44(9):3765-70. PubMed ID: 19493593
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide analogs as novel anti-hepatitis B virus agents.
Iyer RP; Padmanabhan S; Zhang G; Morrey JD; Korba BE
Curr Opin Pharmacol; 2005 Oct; 5(5):520-8. PubMed ID: 16087397
[TBL] [Abstract][Full Text] [Related]
10. SATE pronucleotide approaches: an overview.
Peyrottes S; Egron D; Lefebvre I; Gosselin G; Imbach JL; Périgaud C
Mini Rev Med Chem; 2004 May; 4(4):395-408. PubMed ID: 15134542
[TBL] [Abstract][Full Text] [Related]
11. Could 5'-N and S ProTide analogues work as prodrugs of antiviral agents?
Procházková E; Hřebabecký H; Dejmek M; Šála M; Šmídková M; Tloušťová E; Zborníková E; Eyer L; Růžek D; Nencka R
Bioorg Med Chem Lett; 2020 Feb; 30(4):126897. PubMed ID: 31882298
[TBL] [Abstract][Full Text] [Related]
12. cycloSal-pronucleotides design of chemical trojan horses.
Meier C
Mini Rev Med Chem; 2002 Jun; 2(3):219-34. PubMed ID: 12370064
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antiviral, and antitumor activity of 2-substituted purine methylenecyclopropane analogues of nucleosides.
Qin X; Chen X; Wang K; Polin L; Kern ER; Drach JC; Gullen E; Cheng YC; Zemlicka J
Bioorg Med Chem; 2006 Feb; 14(4):1247-54. PubMed ID: 16242337
[TBL] [Abstract][Full Text] [Related]
14. New insights regarding the potential of the pronucleotide approach in antiviral chemotherapy.
Gosselin G; Girardet JL; Périgaud C; Benzaria S; Lefebvre I; Schlienger N; Pompon A; Imbach JL
Acta Biochim Pol; 1996; 43(1):196-208. PubMed ID: 8790724
[TBL] [Abstract][Full Text] [Related]
15. Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.
Sinokrot H; Smerat T; Najjar A; Karaman R
Molecules; 2017 Oct; 22(10):. PubMed ID: 29035325
[No Abstract] [Full Text] [Related]
16. Synthesis, X-ray crystal structural study, antiviral and cytostatic evaluations of the novel unsaturated acyclic and epoxide nucleoside analogues.
Kristafor V; Raić-Malić S; Cetina M; Kralj M; Suman L; Pavelić K; Balzarini J; De Clercq E; Mintas M
Bioorg Med Chem; 2006 Dec; 14(23):8126-38. PubMed ID: 16889965
[TBL] [Abstract][Full Text] [Related]
17. The ProTides Boom.
Mehellou Y
ChemMedChem; 2016 Jun; 11(11):1114-6. PubMed ID: 27159529
[TBL] [Abstract][Full Text] [Related]
18. Modification of pyrimidine derivatives from antiviral agents to antitumor agents.
Kimura H; Katoh T; Kajimoto T; Node M; Hisaki M; Sugimoto Y; Majima T; Uehara Y; Yamori T
Anticancer Res; 2006; 26(1A):91-7. PubMed ID: 16475684
[TBL] [Abstract][Full Text] [Related]
19. Foreword.
Shuto S
Chem Pharm Bull (Tokyo); 2018; 66(2):116. PubMed ID: 29386460
[No Abstract] [Full Text] [Related]
20. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
